Rouzbeh R. Taghizadeh, Ph.D.
Scientist, Entrepreneur, & Innovator
Is this your profile?
Claim this listing to verify your information, add details, and be discoverable by attorneys searching for expert witnesses.
Professional Summary
Rouzbeh R. Taghizadeh, Ph.D. is a regenerative medicine expert specializing in cellular and tissue therapeutics litigation. With a career spanning regenerative biology, stem cell bioengineering, and biotechnology innovation, he brings a multidisciplinary framework to his litigation work. His work centers on investigating stem cell processing methods, assessing tissue engineering protocols, and evaluating whether regulatory compliance standards have been met.
Dr. Taghizadeh has been retained in numerous expert witness and consulting engagements across the United States, involving cases related to regenerative medicine, biotechnology, and patent infringement. His Ph.D. in Stem Cell Bioengineering from the Massachusetts Institute of Technology, along with his extensive experience in developing novel biotechnologies, reinforce his ability to deliver objective, defensible analyses. He is regularly engaged by both plaintiff and defense counsel to provide clear, independent determinations of causation in disputes involving stem cell and tissue engineering technologies.
Work Experience
Rouzbeh R. Taghizadeh, Ph.D., is the Founder & President at Kendall Innovations, LLC., in Cambridge, Massachusetts, since 2022. He co-founded AuxoCell Laboratories, Inc., serving as Chief Scientific Officer from 2008 to 2023, and was a Co-Founder & Director at the Perinatal Stem Cell Society from 2013 to 2023. His career spans over 28 years, including roles at multiple Massachusetts Institute of Technology (MIT) locations and as a Visiting Scientist at Tufts Medical Center.
Expert Intelligence
Best Descriptor
This expert specializes in regenerative medicine and stem cell therapeutics, providing scientific consulting and leading R&D efforts.
Best Use Cases
- 1consulting for regenerative medicine ventures
- 2developing stem cell therapeutic platforms
- 3conducting pre-clinical and clinical studies
Full analysis available to registered users
View full reportEducation
Post-Doctoral Research Fellow in Regenerative Biology and Cancer
Boston Biomedical Research Institute (BBRI) · 2008
Post-Doctoral Associate in Biological Engineering
Massachusetts Institute of Technology (MIT) · 2008
Ph.D. in Stem Cell Bioengineering
Massachusetts Institute of Technology (MIT) · 2006
B.S. in Chemical Engineering
University of Massachusetts, Amherst · 2000
Ph.D. in Stem Cell Bioengineering
Massachusetts Institute of Technology · 2006
B.S. in Chemical Engineering
University of Massachusetts-Amherst · 2000